[HTML][HTML] Glucagon-like peptide-1 receptor agonists in type 2 diabetes: their use and differential features
KA Lyseng-Williamson - Clinical Drug Investigation, 2019 - Springer
Glucagon-like peptide-1 receptor analogues/agonists (GLP-1RAs) are well established as
effective adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as …
effective adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as …
[HTML][HTML] Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
KA Lyseng-Williamson - Clinical Drug Investigation, 2019 - ncbi.nlm.nih.gov
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are well established as effective
adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as monotherapy or …
adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as monotherapy or …
[PDF][PDF] Glucagon‑Like Peptide‑1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
KA Lyseng‑Williamson - Clinical Drug Investigation, 2019 - sochob.cl
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are well established as effective
adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as monotherapy or …
adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as monotherapy or …
[引用][C] Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
KA Lyseng-Williamson - Clinical Drug Investigation, 2019 - cir.nii.ac.jp
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential
Features | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Features | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Glucagon‑Like Peptide‑1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
KA Lyseng-Williamson - Clinical Drug Investigation, 2019 - search.proquest.com
Glucagon-like peptide-1 receptor agonists (GLP-lRAs) are well established as effective
adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as monotherapy or …
adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as monotherapy or …
Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features
KA Lyseng-Williamson - Clinical drug investigation, 2019 - pubmed.ncbi.nlm.nih.gov
Glucagon-like peptide-1 receptor analogues/agonists (GLP-1RAs) are well established as
effective adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as …
effective adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as …
Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features.
KA Lyseng-Williamson - Clinical Drug Investigation, 2019 - europepmc.org
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are well established as effective
adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as monotherapy or …
adjuncts to lifestyle modification in the treatment of type 2 diabetes (T2D) as monotherapy or …